New CEO Alexander Hardy is wasting no time overhauling rare disease specialist BioMarin, with the company’s chief commercial officer now headed for the exits. Jeffrey Ajer, who’s been with the company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback